Literature DB >> 17177978

Altered immune function of monocytes in different stages of patients with acute on chronic liver failure.

T Xing1, L Li, H Cao, J Huang.   

Abstract

The aim of this study was to investigate the characteristics of the immune function of monocytes in different stages of the patients with acute on chronic liver failure (ACLF). Human leucocyte antigen (HLA)-DR and Toll-like receptor 4 (TLR-4) expression on monocytes in early and late stages of acute on chronic liver failure were detected by flow cytometry. The secretion function of monocytes was measured by cytometric bead array. Compared with healthy controls, the levels of HLA-DR expression on monocytes in patients with chronic hepatitis B, liver cirrhosis and acute on chronic liver failure were gradually decreased, especially in the late stage of acute on chronic liver failure (P < 0.001). TLR-4 expression on monocytes in patients with liver cirrhosis and acute on chronic liver failure were higher than the healthy controls. The concentrations of interleukin (IL)-1beta, tumour necrosis factor (TNF)-alpha and IL-12p70 in early-stage ACLF were significantly higher compared with healthy controls and lower in late-stage ACLF (P < 0.01, 0.05). However, a significantly lower amount of IL-10 was found on monocytes in early-stage ACLF than that of late-stage ACLF and healthy controls (P < 0.01). Monocyte HLA-DR expression in patients who died was significantly lower compared with patients who survived in the early and late stages of ACLF (P < 0.01). The dynamic detection of HLA-DR expression or cytokines secreted from monocytes could contribute to the estimation of the status of the immune function of patients with acute on chronic liver failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177978      PMCID: PMC1810435          DOI: 10.1111/j.1365-2249.2006.03259.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure.

Authors:  Eiichiro Yumoto; Toshihiro Higashi; Kazuhiro Nouso; Harushige Nakatsukasa; Keishi Fujiwara; Tadashi Hanafusa; Yasuhiro Yumoto; Tadao Tanimoto; Masashi Kurimoto; Noriaki Tanaka; Takao Tsuji
Journal:  J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 4.029

Review 2.  Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review.

Authors:  J M Cavaillon; M Adib-Conquy; I Cloëz-Tayarani; C Fitting
Journal:  J Endotoxin Res       Date:  2001

3.  Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13.

Authors:  T van der Poll; R de Waal Malefyt; S M Coyle; S F Lowry
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

Review 4.  Classification, etiology, and considerations of outcome in acute liver failure.

Authors:  R Williams
Journal:  Semin Liver Dis       Date:  1996-11       Impact factor: 6.115

5.  Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis.

Authors:  Stephen M Riordan; Narelle Skinner; Ammar Nagree; Helen McCallum; Christopher J McIver; Jelica Kurtovic; John A Hamilton; Stig Bengmark; Roger Williams; Kumar Visvanathan
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

Review 6.  The human leukocyte antigens and their relationship to infection.

Authors:  W G Cheadle
Journal:  Am J Surg       Date:  1993-02       Impact factor: 2.565

7.  Downregulation of proinflammatory cytokine release in whole blood from septic patients.

Authors:  W Ertel; J P Kremer; J Kenney; U Steckholzer; D Jarrar; O Trentz; F W Schildberg
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

8.  Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness.

Authors:  Fabio Re; Jack L Strominger
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.

Authors:  R S Lin; F Y Lee; S D Lee; Y T Tsai; H C Lin; R H Lu; W C Hsu; C C Huang; S S Wang; K J Lo
Journal:  J Hepatol       Date:  1995-02       Impact factor: 25.083

View more
  41 in total

1.  The impact of acute strenuous exercise on TLR2, TLR4 and HLA.DR expression on human blood monocytes induced by autologous serum.

Authors:  Stephen Booth; Geraint D Florida-James; Brian K McFarlin; Guillaume Spielmann; Daniel P O'Connor; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2010-08-27       Impact factor: 3.078

2.  Mammary duct ectasia in a man with liver disease, end stage renal failure, and adjacent arteriovenous fistula.

Authors:  Elliot Dickerson; Raye Budway; Ramana Surampudi; Ellen Tabor
Journal:  J Radiol Case Rep       Date:  2010-08-01

Review 3.  Acute-on-chronic Liver Failure.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Curr Gastroenterol Rep       Date:  2016-12

4.  Role of monocytes and macrophages in experimental and human acute liver failure.

Authors:  Lucia A Possamai; Charalambos Gustav Antoniades; Quentin M Anstee; Alberto Quaglia; Diego Vergani; Mark Thursz; Julia Wendon
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

Review 5.  Management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Vicente Arroyo; Javier Fernández
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

6.  Expression of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure.

Authors:  Ling Gao; Jie-Fei Wang; Ming Xiang; Yu-Chen Fan; Zheng-Guo Zhang; Kai Wang
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

Review 7.  Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure.

Authors:  En-Qiang Chen; Fan Zeng; Ling-Yun Zhou; Hong Tang
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  Hemorrhagic varicella in chronic liver disease.

Authors:  Chandra Madhur Sharma; Deepti Sharma; Ravi Prakash Agrawal
Journal:  J Glob Infect Dis       Date:  2014-01

Review 9.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

10.  Upregulation of toll-like receptor 4 on T cells in PBMCs is associated with disease aggravation of HBV-related acute-on-chronic liver failure.

Authors:  Chun-Li Xu; You-Hua Hao; Yin-Ping Lu; Zong-Sheng Tang; Xue-Cheng Yang; Jun Wu; Xin Zheng; Bao-Ju Wang; Jia Liu; Dong-Liang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.